Dr. Rajiv Agarwal is a tenured Professor of Medicine at Indiana University School of Medicine at Indianapolis, IN. Dr. Agarwal earned his medical degree from the All India Institute of Medical Sciences in New Delhi. After completing residency in Internal Medicine at the same institution he completed a Nephrology fellowship at University of Texas, Southwestern Dallas.
In July 1997, he joined Indiana University as Clinical Assistant Professor and within 10 years was promoted to the rank of full Professor. Dr. Agarwal has published about 250 original papers and reviews in Nephrology. He has had numerous invited lectures including those from national societies such as National Kidney Foundation, American Society Nephrology, International Society of Nephrology, European Dialysis and Transplant Association, and the American Heart Association. Dr. Agarwal has received the Indiana University Trustee’s teaching award and the young scholar award of the American Society of Hypertension. He serves on the Editorial Board of Kidney International, CJASN, Hypertension and Seminars in Dialysis and as an Editor for Nephrology Dialysis Transplantation, American Journal of Nephrology, and Journal of the American Society of Hypertension. He also served as an Associate Editor of NephSAP for 6 years.
Dr. Agarwal is an internationally recognized leader in the area of clinical and translational research in nephrology. He was amongst the first to demonstrate the effect of add-on angiotensin receptor blockade on cytokine production and oxidative stress, but none on proteinuria in patients with chronic kidney disease. He has developed a technique for measurement of oxidative stress biomarkers using HPLC and applied this method to demonstrate generation of oxidative stress with intravenous iron in patients with chronic kidney disease. He was the first to describe the antiproteinuric effects of vitamin D receptor activators. His research on anemia and iron management among patients with CKD is broadly recognized. His foremost contribution has been in the area of hypertension in hemodialysis patients for which he has been funded continuously since 2003 by the National Institutes of Health. He has refined the techniques to diagnose and treat hypertension in this complex group of patients and performed important randomized trials in this difficult group of patients. He serves on the Board of Directors of KDIGO, has served as a panelist for Medical Evidence Development Coverage Advisory Committee (MEDCAC) for United States Medicare, and most recently contributed a chapter on the Approach to the patient with renal disease in Cecil’s Textbook of Medicine.
The special award will be presented to Dr Agarwal in Atlanta at Renal week 2013 ANIO event.
